US Patent Issued to ADVACCINE (SUZHOU) BIOPHARMACEUTICALS on July 28 for "Vaccine for preventing and treating Merkel cell carcinoma" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,168, issued on July 28, was assigned to ADVACCINE (SUZHOU) BIOPHARMACEUTICALS Co. LTD. (Suzhou, China).

"Vaccine for preventing and treating Merkel cell carcinoma" was invented by Yue He (Suzhou, China), Gan Zhao (Suzhou, China), Lunan Zhang (Suzhou, China), Xin Cheng (Suzhou, China) and Qingling Yu (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a novel vaccine for preventing and treating Merkel cell carcinoma. The present invention constructs a therapeutic vaccine based on a Merkel cell polyomavirus capsid protein VP1 by taking the Merkel cell polyomavirus capsid protein VP1 as an antigen, in combinatio...